ePHex: a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria.
Saved in:
| Title: | ePHex: a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria. |
|---|---|
| Authors: | Ariceta, Gema1 gariceta@vhebron.net, Collard, Laure2, Abroug, Saoussen3, Moochhala, Shabbir H.4, Gould, Edward5, Boussetta, Abir6, Ben Hmida, Mohamed7, De, Sudarsana8, Hunley, Tracy E.5, Jarraya, Faical7, Fraga, Gloria1,9, Banos, Ana10, Lindner, Elisabeth10, Dehmel, Bastian10, Schalk, Gesa11 |
| Source: | Pediatric Nephrology. Feb2023, Vol. 38 Issue 2, p403-415. 13p. 1 Diagram, 4 Charts, 3 Graphs. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 0931041X |
|---|---|
| DOI: | 10.1007/s00467-022-05591-5 |
